Results for tag: "Neurotrophic Keratopathy Drug"

Neurotrophic Keratopathy (NK) is a rare disorder of the cornea, the clear outer layer of the eye, caused by a lack of nerve supply to the cornea. It is characterized by a decrease in corneal sensation, leading to dryness, ulceration, and scarring. Treatment of NK is focused on restoring corneal sensation and preventing further damage. Optical Disorders Drugs are used to treat a variety of eye diseases, including NK. These drugs are typically administered topically, either as eye drops or ointments. Commonly used drugs include corticosteroids, antibiotics, and anti-inflammatory agents. In some cases, surgery may be necessary to restore corneal sensation. The Neurotrophic Keratopathy Drug market is a specialized segment of the Optical Disorders Drugs market. It is composed of a variety of drugs used to treat NK, including corticosteroids, antibiotics, and anti-inflammatory agents. These drugs are typically administered topically, either as eye drops or ointments. Some companies in the Neurotrophic Keratopathy Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more